Neptune Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.67 M
- Company Age 19 Year, 11 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.29 Cr
- Revenue Growth 2.24%
- Profit Growth 14.72%
- Ebitda -19.76%
- Net Worth 17.64%
- Total Assets 6.36%
About Neptune Lifesciences
Neptune Lifesciences Pvt Ltd (NLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 February 2006 and has a history of 19 years. Its registered office is in Solan H P, Himachal Pradesh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.67 M.
The company currently has active open charges totaling ₹7.29 Cr.
Ravinder Singh and Parwinder Kumar serve as directors at the Company.
Company Details
- Location Solan H P, Himachal Pradesh
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230HP2006PTC029637
-
Company No.
029637
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Feb 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
What products or services does Neptune Lifesciences Pvt Ltd offer?
Neptune Lifesciences Pvt Ltd offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Common Disease Medicines, Psoriasis Ointment, Digestive System Drugs & Medicines, Antacid Drugs, Anti Acne Drug, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Neptune Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravinder Singh
|
Director | 02-Feb-2006 | Current |
|
Parwinder Kumar
|
Director | 02-Feb-2006 | Current |
Financial Performance of Neptune Lifesciences.
Neptune Lifesciences Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 2.24% increase. The company also saw a substantial improvement in profitability, with a 14.72% increase in profit. The company's net worth Soared by an impressive increase of 17.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neptune Lifesciences?
Unlock access to Neptune Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Neptune Lifecare Private LimitedRavinder Singh and Parwinder Kumar are mutual person
-
Neptune Health & Beauty Care Private LimitedRavinder Singh and Parwinder Kumar are mutual person
Charges (Loans)
₹7.29 Cr
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 6.81 Cr
- Hdfc Bank Limited : 0.26 Cr
- Director Of Industries Through Dy. Director Of Industries : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jul 2023 | Uco Bank | ₹5.70 M | Open |
| 28 Apr 2022 | Uco Bank | ₹2.94 M | Open |
| 28 Apr 2022 | Uco Bank | ₹2.94 M | Open |
| 21 Oct 2020 | Hdfc Bank Limited | ₹2.60 M | Open |
| 08 Feb 2011 | Uco Bank | ₹3.50 M | Open |
How Many Employees Work at Neptune Lifesciences?
Neptune Lifesciences has a workforce of 62 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neptune Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neptune Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
